Trademarkia Logo

Canada

C$
Trademark Search in Canada
ENTASIS THERAPEUTICS & DESIGN
ENTASIS THERAPEUTICS & DESIGN
REGISTERED

on 30 Aug 2021

Last Applicant/ Owned by

ENTASIS THERAPEUTICS LTD.

2 Kingdom StreetLondon, England, W2 6BD

GB

Serial Number

1872023 filed on 8th Dec 2017

Registration Number

TMA1104996 registered on 30th Aug 2021

Registration expiry Date

30th Aug 2031

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

ENTASIS THERAPEUTICS & DESIGN

Trademark usage description

pharmaceutical preparations, namely, anti-infectives and antibiotics; pharmaceutical preparations for the treatment of infectious diseases, namely bac Read More

Vienna Information


27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 14

Letters repeated by mirror effect or symmetrically in any positionLettres répétées par effet de miroir ou symétriquement dans une position quelconque

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 15

Letters or numerals representing an objectLettres ou chiffres représentant un objet

24 . 11 . 7

Neptune's tridentsTridents de Neptune

Classification Information


Class [005]
Pharmaceutical preparations, namely, anti-infectives and antibiotics; pharmaceutical preparations for the treatment of infectious diseases, namely bacterial infections, viral infections, fungal infections, respiratory infections, eye infections, urinary tract infections; pharmaceutical preparations for the treatment of cardiovascular diseases, oncological diseases and disorders, respiratory diseases and disorders, sexually transmitted diseases, dental and oral diseases, gastro-intestinal diseases, ophthalmological diseases and disorders, and autoimmune diseases; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central and peripheral nervous system, namely, the diseases, disorders and infections of the brain, spinal cord, autonomic nervous system, somatic nervous system, movement, ocular motility, and related cartilage and tissue; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the musculoskeletal system, namely, diseases, disorders and infections of the bones of the skeleton, muscles, cartilage, tendons, ligaments, joints, and connective tissues that supports and binds tissues and organs together; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparation for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; dietetic food and substances adapted for medical use for promoting immune system health, namely immune boosters, probiotics, and vitamin and mineral supplements; dietary supplements for humans for promoting immune system health, namely immune boosters, probiotics, and vitamin and mineral supplements.


Classification kind code

11

Class [010]
Surgical instruments, medical instruments for treating infective disease, namely bacterial infection; dental instruments; artificial limbs, eyes, and teeth; suture materials.


Classification kind code

11

Class [042]
Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals, drugs and antibiotics; conducting clinical trials for others; information, advisory and consultancy services in relation to the services of research and development in the pharmaceutical field, services of research in the field of pharmaceuticals, drugs and antibiotics, and services of conducting clinical trials for others


Classification kind code

11

Class [044]
Medical services for the treatment of infectious diseases, namely bacterial infections, viral infections, fungal infections, respiratory infections, eye infections, urinary tract infections; medical services for the treatment of cardiovascular diseases, oncological diseases and disorders, respiratory diseases and disorders, diseases of the central and peripheral nervous system, sexually transmitted diseases, dental and oral diseases, gastro-intestinal diseases, ophthalmological diseases and disorders, autoimmune diseases, and musculoskeletal diseases; medical services for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; medical services for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; medical services for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; information, advisory and consultancy services of providing information in the fields of health, medicine, and pharmaceuticals for the treatment of infectious diseases, namely bacterial infections, viral infections, fungal infections, respiratory infections, eye infections, urinary tract infections; information, advisory and consultancy services of providing information in the fields of health, medicine, and pharmaceuticals for the treatment of cardiovascular diseases, oncological diseases and disorders, respiratory diseases and disorders, diseases of the central and peripheral nervous system, sexually transmitted diseases, dental and oral diseases, gastro-intestinal diseases, ophthalmological diseases and disorders, autoimmune diseases, and musculoskeletal diseases; information, advisory and consultancy services of providing information in the fields of health, medicine, and pharmaceuticals for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; information, advisory and consultancy services of providing information in the fields of health, medicine, and pharmaceuticals for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; information, advisory and consultancy services of providing information in the fields of health, medicine, and pharmaceuticals for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders


Classification kind code

11

Mark Details


Serial Number

1872023

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 16th Dec 2020
Advertised
Submitted for opposition 26
on 17th Nov 2020
Approved
Submitted for opposition 27
on 17th Nov 2020
Approval Notice Sent
Submitted for opposition 15
on 27th Sept 2019
Correspondence Created
Submitted for opposition 15
on 27th Feb 2019
Correspondence Created
Submitted for opposition 22
on 29th Jan 2019
Search Recorded
Submitted for opposition 20
on 29th Jan 2019
Examiner's First Report
Submitted for opposition 31
on 13th Dec 2017
Formalized
Submitted for opposition 1
on 11th Dec 2017
Created
Submitted for opposition 30
on 8th Dec 2017
Filed